After 10 Years of Alzheimer’s Clinical Trials, Eli Lilly’s Solanezumab Fails
Recently, Eli Lilly announced that their anti-amyloid drug solanezumab failed to prevent Alzheimer’s in cognitively healthy older individuals who showed amyloid plaque accumulation in…